Ultragenyx Pharmaceutical Inc. (RARE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 657M | 951M | 643.21M | 719.79M | 699.15M | 817.12M | 799.61M | 964.64M | 595.97M | 732.18M | 599.19M | 702.14M |
| Cash & Short-Term Investments | 413M | 693M | 435.07M | 477.38M | 494.44M | 610.02M | 621.61M | 763.82M | 412.08M | 577.21M | 442.09M | 551.98M |
| Cash Only | 175M | 434M | 212.34M | 166.11M | 127.06M | 173.73M | 150.62M | 480.69M | 112.25M | 213.58M | 72.58M | 102.06M |
| Short-Term Investments | 238M | 259M | 222.74M | 311.28M | 367.38M | 436.3M | 470.99M | 283.13M | 299.83M | 363.63M | 369.52M | 449.92M |
| Accounts Receivable | 121M | 159M | 114.64M | 124.46M | 98.84M | 121.8M | 93.3M | 105.98M | 100.25M | 73.39M | 79.26M | 70.52M |
| Days Sales Outstanding | 92.65 | 60.81 | 68.77 | 61.02 | 71.28 | 60.01 | 65.72 | 63.82 | 72.6 | 55.12 | 70.27 | 47.69 |
| Inventory | 55M | 52M | 52.2M | 46.5M | 46.03M | 45.01M | 43.33M | 40.14M | 35.91M | 33.97M | 31.8M | 28.26M |
| Days Inventory Outstanding | 160.5 | 165.28 | 162.2 | 183.03 | 142.93 | 240.54 | 182.66 | 162.59 | 181.34 | 251.06 | 251.45 | 251.83 |
| Other Current Assets | 68M | 47M | 41.29M | 71.44M | 59.84M | 40.29M | 41.37M | 54.7M | 47.73M | 47.62M | 46.03M | 51.38M |
| Total Non-Current Assets | 639M | 581M | 547.24M | 586.48M | 612.77M | 686.33M | 738.75M | 653.8M | 711.11M | 758.83M | 638.95M | 609.17M |
| Property, Plant & Equipment | 239M | 267M | 249.96M | 255.76M | 260.91M | 265.93M | 272.45M | 278.71M | 285.11M | 290.57M | 323.24M | 308.21M |
| Fixed Asset Turnover | 0.54x | 0.80x | 0.63x | 0.64x | 0.53x | 0.61x | 0.51x | 0.52x | 0.38x | 0.42x | 0.31x | 0.36x |
| Goodwill | 44M | 44M | 44.41M | 44.41M | 44.41M | 44.41M | 44.41M | 44.41M | 44.41M | 44.41M | 44.41M | 44.41M |
| Intangible Assets | 174M | 176M | 172.94M | 174.73M | 176.52M | 178.31M | 164.94M | 166.24M | 165.04M | 166.27M | 157.3M | 158.24M |
| Long-Term Investments | 0 | 59M | 22.07M | 51.45M | 68.56M | 135M | 203.09M | 110.67M | 156.58M | 199.9M | 86.11M | 71.83M |
| Other Non-Current Assets | 182M | 35M | 57.86M | 60.12M | 62.37M | 62.68M | 53.87M | 53.77M | 59.97M | 57.69M | 27.9M | 26.49M |
| Total Assets | 1.3B | 1.53B | 1.19B | 1.31B | 1.31B | 1.5B | 1.54B | 1.62B | 1.31B | 1.49B | 1.24B | 1.31B |
| Asset Turnover | 0.10x | 0.15x | 0.13x | 0.13x | 0.10x | 0.11x | 0.09x | 0.10x | 0.08x | 0.09x | 0.08x | 0.08x |
| Asset Growth % | -1.21% | 1.9% | -22.62% | -19.29% | 0.37% | 0.83% | 24.25% | 23.42% | -5.52% | -3.52% | -23.5% | -0.71% |
| Total Current Liabilities | 325M | 384M | 340.02M | 293.24M | 291.67M | 344.15M | 285.01M | 272.87M | 245.57M | 280.44M | 253.98M | 244.38M |
| Accounts Payable | 42M | 31M | 40.57M | 34.24M | 47.45M | 38.76M | 35.99M | 59.81M | 40.97M | 42.11M | 33.36M | 42.12M |
| Days Payables Outstanding | 109.5 | 113.53 | 122.95 | 161.59 | 135.35 | 203.52 | 209.63 | 215.48 | 215.62 | 288.08 | 315.98 | 463.98 |
| Short-Term Debt | 0 | 81M | 65.55M | 0 | 0 | 0 | 10.42M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 283M | 183M | 1.24M | 114.42M | 100.44M | 87.47M | 155.67M | 74.89M | 42.69M | 46.27M | 29.93M | 23.72M |
| Current Ratio | 2.02x | 2.48x | 1.89x | 2.45x | 2.40x | 2.37x | 2.81x | 3.54x | 2.43x | 2.61x | 2.36x | 2.87x |
| Quick Ratio | 1.85x | 2.34x | 1.74x | 2.30x | 2.24x | 2.24x | 2.65x | 3.39x | 2.28x | 2.49x | 2.23x | 2.76x |
| Cash Conversion Cycle | 143.65 | 112.56 | 108.02 | 82.46 | 78.87 | 97.03 | 38.74 | 10.94 | 38.31 | 18.1 | 5.74 | -164.46 |
| Total Non-Current Liabilities | 1.2B | 1.22B | 834.26M | 854.74M | 869.01M | 897.01M | 899.53M | 913.15M | 921.24M | 935.16M | 952.45M | 937.9M |
| Long-Term Debt | 0 | 1.17B | 785.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 24M | 21.69M | 24.53M | 27.79M | 30.04M | 23.66M | 25.74M | 27.98M | 30.57M | 34.55M | 14.85M |
| Deferred Tax Liabilities | 30M | 30M | 30.06M | 30.06M | 30.06M | 30.06M | 30.06M | 30.06M | 30.06M | 30.06M | 31.67M | 31.67M |
| Other Non-Current Liabilities | 1.17B | -4M | -2.91M | 800.15M | 811.17M | 836.91M | 845.81M | 857.35M | 863.2M | 874.53M | 886.23M | 891.39M |
| Total Liabilities | 1.52B | 1.6B | 1.17B | 1.15B | 1.16B | 1.24B | 1.18B | 1.19B | 1.17B | 1.22B | 1.21B | 1.18B |
| Total Debt | 0 | 1.28B | 884.8M | 36.3M | 38.27M | 40.34M | 34.08M | 37.46M | 40.76M | 43.17M | 46.62M | 25.73M |
| Net Debt | -175M | 842M | 672.47M | -129.81M | -88.78M | -133.39M | -116.54M | -443.24M | -71.49M | -170.41M | -25.95M | -76.33M |
| Debt / Equity | - | - | 54.76x | 0.23x | 0.25x | 0.15x | 0.10x | 0.09x | 0.29x | 0.16x | 1.47x | 0.20x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -8.05x | -6.00x | -11.69x | -7.12x | -9.44x | -7.59x | -7.48x | -7.19x | -9.74x | -6.32x | -8.00x | -9.35x |
| Total Equity | -229M | -73M | 16.16M | 158.29M | 151.25M | 262.3M | 353.83M | 432.42M | 140.26M | 275.41M | 31.71M | 129.03M |
| Equity Growth % | -251.41% | -127.83% | -95.43% | -63.4% | 7.83% | -4.76% | 1015.68% | 235.13% | -36.38% | -21.87% | -93.24% | -80.97% |
| Book Value per Share | -2.28 | -0.73 | 0.16 | 1.61 | 1.57 | 2.74 | 3.71 | 4.99 | 1.66 | 3.40 | 0.44 | 1.82 |
| Total Shareholders' Equity | -236M | -80M | 9.16M | 151.29M | 144.25M | 255.3M | 346.83M | 432.42M | 140.26M | 275.41M | 31.71M | 129.03M |
| Common Stock | 0 | 0 | 96K | 96K | 94K | 92K | 92K | 92K | 83K | 82K | 72K | 71K |
| Retained Earnings | -4.72B | -4.53B | -4.4B | -4.22B | -4.11B | -3.96B | -3.82B | -3.69B | -3.56B | -3.39B | -3.26B | -3.1B |
| Treasury Stock | 0 | -8M | -7.99M | -7.99M | -7.57M | -3.59M | -3.56M | -3.4M | -3.33M | -432K | -381K | -381K |
| Accumulated OCI | 0 | 9M | 8.81M | -268K | -341K | -643K | 896K | -1.09M | -431K | 647K | -2.24M | -3.1M |
| Minority Interest | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 0 | 0 | 0 | 0 | 0 |